241 related articles for article (PubMed ID: 26790669)
21. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.
Gutschenritter T; Machiorlatti M; Vesely S; Ahmad B; Razaq W; Razaq M
Anticancer Res; 2017 Sep; 37(9):5019-5025. PubMed ID: 28870928
[TBL] [Abstract][Full Text] [Related]
23. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
Kusafuka K; Kawasaki T; Maeda M; Yamanegi K; Baba S; Ito Y; Inagaki H; Nakajima T
Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
[TBL] [Abstract][Full Text] [Related]
25. Survival Outcome of Intermediate-Grade Salivary Gland Carcinoma.
Park GC; Roh JL; Cho KJ; Jung YG; Lee HW; Kim TG; Choi SH; Nam SY; Kim SY
Oncology; 2018; 94(2):125-132. PubMed ID: 29151106
[TBL] [Abstract][Full Text] [Related]
26. The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
Kusafuka K; Sato Y; Nakatani E; Baba S; Maeda M; Yamanegi K; Ueda K; Inagaki H; Otsuki Y; Kuroda N; Suzuki K; Iwai H; Imamura Y; Itakura J; Yamanaka S; Takahashi H; Ito I; Akashi T; Daa T; Hamada M; Yasuda M; Kawata R; Yamamoto H; Tachibana Y; Fukuoka J; Muramatsu A; Arai K; Suzuki M
Head Neck; 2022 Jun; 44(6):1430-1441. PubMed ID: 35352425
[TBL] [Abstract][Full Text] [Related]
27. Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.
Kim JY; Lee S; Cho KJ; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Shin HS; Chang SK; Ahn SD
Br J Radiol; 2012 Oct; 85(1018):e947-52. PubMed ID: 22573301
[TBL] [Abstract][Full Text] [Related]
28. Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.
Johnston ML; Huang SH; Waldron JN; Atenafu EG; Chan K; Cummings BJ; Gilbert RW; Goldstein D; Gullane PJ; Irish JC; Perez-Ordonez B; Weinreb I; Bayley A; Cho J; Dawson LA; Hope A; Ringash J; Witterick IJ; O'Sullivan B; Kim J
Head Neck; 2016 Apr; 38 Suppl 1():E820-6. PubMed ID: 25916947
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in patients with malignant salivary gland neoplasms in a Brazilian population.
Oliveira LR; Soave DF; Oliveira-Costa JP; Zorgetto VA; Ribeiro-Silva A
Asian Pac J Cancer Prev; 2011; 12(2):363-8. PubMed ID: 21545195
[TBL] [Abstract][Full Text] [Related]
30. HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report.
Murata K; Kawahara A; Ono T; Takase Y; Abe H; Naito Y; Akiba J
Diagn Cytopathol; 2018 May; 46(5):429-433. PubMed ID: 29205961
[TBL] [Abstract][Full Text] [Related]
31. Salivary duct carcinoma: a Danish national study.
Breinholt H; Elhakim MT; Godballe C; Andersen LJ; Primdahl H; Kristensen CA; Bjørndal K
J Oral Pathol Med; 2016 Oct; 45(9):664-671. PubMed ID: 26822194
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population.
Liu S; Ow A; Ruan M; Yang W; Zhang C; Wang L; Zhang C
Int J Oral Maxillofac Surg; 2014 Jun; 43(6):667-73. PubMed ID: 24568836
[TBL] [Abstract][Full Text] [Related]
33. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
[TBL] [Abstract][Full Text] [Related]
34. Primary salivary duct carcinoma arising from the Stensen duct.
Noda K; Hirano T; Okamoto T; Suzuki M
Ear Nose Throat J; 2016 Sep; 95(9):E15-7. PubMed ID: 27657321
[TBL] [Abstract][Full Text] [Related]
35. Prognostic models for estimating survival of salivary duct carcinoma: a population-based study.
Zhang D; Li L
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1939-1954. PubMed ID: 36422671
[TBL] [Abstract][Full Text] [Related]
36. Salivary-duct carcinoma (SDC): A rare case report.
Li Z; Zhou Q; Wang Y; Li G
Asian J Surg; 2024 May; 47(5):2441-2442. PubMed ID: 38302356
[No Abstract] [Full Text] [Related]
37. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.
Sousa LG; Wang K; Torman D; Binks BJ; Rubin ML; Andersen CR; Lewis WE; Rivera MJ; Kaya D; El-Naggar AK; Hanna EY; Esmaeli B; Frank SJ; Bell D; Glisson BS; Rodon J; Meric-Bernstam F; Lee JJ; Ferrarotto R
Cancer; 2022 Feb; 128(3):509-518. PubMed ID: 34661906
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas.
Zeidan YH; Shultz DB; Murphy JD; An Y; Chan C; Kaplan MJ; Colevas AD; Kong C; Chang DT; Le QT
Laryngoscope; 2013 Nov; 123(11):2675-80. PubMed ID: 23553253
[TBL] [Abstract][Full Text] [Related]
39. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
Griffith CC; Thompson LD; Assaad A; Purgina BM; Lai C; Bauman JE; Weinreb I; Seethala RR; Chiosea SI
Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
[TBL] [Abstract][Full Text] [Related]
40. Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation.
Kawahara A; Harada H; Akiba J; Kage M
Diagn Cytopathol; 2008 Jul; 36(7):485-93. PubMed ID: 18528886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
